|
|
楼主 |
发表于 2025-5-3 20:37:44
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑
# X. X4 f/ n% |, C. Q1 Z
, L1 c' f+ R' t& k+ N- i; m今年ASCO大会，肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU，腹部肿瘤和生物治疗科今年哑火了
4 L: _5 N9 R. |5 p, g4 v$ ]
6 P! N4 L9 G0 K6 A N头颈肿瘤BU入选ASCO 2025的研究% T3 \+ k/ Q, {- ?
Hot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.' |( w$ d& |% Q% i
肿瘤内科-头颈肿瘤科姜愚团队5 {3 n9 u! k' ?( V% a
6 L- b" _4 t/ Q2 \. l' s% _4 YNeoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial.2 d8 o' @0 H3 |, h
肿瘤内科-头颈肿瘤科刘磊团队. e) S& W% p8 d" e# w1 A
' d/ }* ~# Q6 ]/ L% L8 q4 D& |
A phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy.. Q _9 a. ~3 y" q' v b
肿瘤内科-头颈肿瘤科刘磊团队
7 ^, v# P3 A# {9 M2 {: O
; m% n9 L0 Y5 S) |2 _; s3 c( zA phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy.
) I0 P! Q0 e" R4 n) B1 Q: E# ]% C肿瘤内科-头颈肿瘤科刘磊团队, K! O) c+ X: t$ w' K+ i
: E# q! i6 a/ w: X/ Mribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.
9 O3 Y/ Q2 e0 ^. v1 L肿瘤内科-头颈肿瘤科姜愚团队6 y# B4 F6 v& @( @6 P( J1 R) Z
|
|
[复制链接]
发表于 2025-5-9 16:51:15
